Labcorp Holdings Inc. reported second quarter 2026 results with revenue of $3.73 billion, a 5.8% increase year-over-year, and diluted EPS of $3.64, up 28.5%. The company raised its full-year guidance, setting enterprise revenue growth at 5.4% to 6.3% and adjusted EPS between $18.10 and $18.55. Labcorp announced a $1.0 billion increase in share repurchase authorization, bringing the remaining total to $1.4 billion. Additionally, the Board approved a quarterly cash dividend of $0.72 per share, payable on September 11, 2026, to stockholders of record as of August 28, 2026. The company operates in the healthcare diagnostics and clinical laboratory services industry.

Labcorp Holdings Inc. (NYSE: LH) declared a cash dividend of $0.72 per share of common stock, payable on September 11, 2026, to stockholders of record as of August 28, 2026. Labcorp Holdings Inc. is a global provider of laboratory services.

Labcorp Holdings Inc. has announced its financial results for the first quarter of 2026. This filing is a critical update for investors to evaluate the company's recent operational performance, revenue trends, and ability to meet quarterly earnings expectations.

Labcorp Holdings Inc. has filed an 8-K to announce its financial results for the fourth quarter and full year of 2025. This disclosure is a key event for investors as it provides the company's latest operational performance and annual financial health metrics.